NorthWest Biotherapeutics Inc (NWBO)

[JerryCampbell]

There most certainly is a Subsequent Events section. Note 15.

In the PDF, use CTRL-F to search on "Subsequent Events". You will find 2 earlier notes that refer the reader to it, then the actual section. It starts as follows.

15. Subsequent Events

Debt Offering

On March 1, 2021, the Company entered into a Commercial Loan Agreement (the “Note”) with an individual investor for an aggregate principal amount of $10 million. The Note bears interest at 8% per annum with a 22-month term. There are no repayments during the first 8 months of the term. The note is amortized in 14 installments starting on November 1, 2021. The Note carries an original issue discount of $1 million and $5,000 legal costs that were reimbursable to the investor.

Warrants and Options Suspension

On January 15, 2021, the Company further extended the suspension of approximately 256 million warrants and options held by certain officers and directors of the Company until February 28, 2021.

On February 28, 2021, the Company further extended the suspension of approximately 262 million warrants and options held by certain officers and directors of the Company until April 30, 2021.

A total 262 million warrants and options will be suspended until April 30, 2021.